{ "cik": 1395937, "cik_padded": "0001395937", "entityName": "Syndax Pharmaceuticals Inc", "fiscal_years": [ { "accn": "0001193125-26-076536", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 187000.0, "cash": 134930000.0, "eps_diluted": -3.29, "free_cash_flow": -323167000.0, "net_income": -285422000.0, "operating_cash_flow": -322980000.0, "operating_income": -273084000.0, "revenue": 172352000.0, "stockholders_equity": 64630000.0, "total_assets": 529706000.0, "total_liabilities": 465076000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 7.195977100417763, "revenue_growth_yoy": 6.278378378378378, "roa_avg2y": -0.4550290867756803, "roa_period_end": -0.5388309741630263, "roe_avg2y": -1.6182495450087029, "roe_period_end": -4.416246325235958 } }, { "accn": "0001193125-26-076536", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 154083000.0, "eps_diluted": -3.72, "free_cash_flow": -274903000.0, "net_income": -318758000.0, "operating_cash_flow": -274903000.0, "operating_income": -339672000.0, "revenue": 23680000.0, "stockholders_equity": 288124000.0, "total_assets": 724816000.0, "total_liabilities": 436692000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.5156390998320168, "roa_avg2y": -0.47657763796856684, "roa_period_end": -0.43977781947418376, "roe_avg2y": -0.7568572514008928, "roe_period_end": -1.106322277908123 } }, { "accn": "0001193125-26-076536", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 295394000.0, "eps_diluted": -2.98, "free_cash_flow": -160601000.0, "net_income": -209360000.0, "operating_cash_flow": -160601000.0, "operating_income": -229954000.0, "stockholders_equity": 554196000.0, "total_assets": 612880000.0, "total_liabilities": 58684000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10589033482738959, "roa_avg2y": -0.3771858076092949, "roa_period_end": -0.3416003132750294, "roe_avg2y": -0.4098488222425598, "roe_period_end": -0.3777724848248634 } }, { "accn": "0001193125-26-076536", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 74356000.0, "eps_diluted": -2.46, "free_cash_flow": -133675000.0, "net_income": -149338000.0, "operating_cash_flow": -133675000.0, "operating_income": -151757000.0, "stockholders_equity": 467449000.0, "total_assets": 497236000.0, "total_liabilities": 29787000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06372245956243355, "roa_avg2y": -0.3154274030962316, "roa_period_end": -0.3003362588388612, "roe_avg2y": -0.34102557954458523, "roe_period_end": -0.31947442394785314 } }, { "accn": "0000950170-25-030394", "filed": "2025-03-03", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 129000.0, "cash": 221965000.0, "eps_diluted": 0.46, "free_cash_flow": 29002000.0, "net_income": 24926000.0, "operating_cash_flow": 29131000.0, "operating_income": 26220000.0, "revenue": 139709000.0, "stockholders_equity": 408368000.0, "total_assets": 449657000.0, "total_liabilities": 41289000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10110733456098421, "net_margin": 0.17841370276789612, "operating_margin": 0.18767581186609308, "revenue_growth_yoy": 91.09558338826632, "roa_avg2y": 0.06644541298465885, "roa_period_end": 0.05543336365273976, "roe_avg2y": 0.07546975578149316, "roe_period_end": 0.06103808329741802 } }, { "accn": "0001564590-22-008112", "filed": "2024-02-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 115243000.0, "eps_diluted": -1.87, "free_cash_flow": -71260000.0, "net_income": -73158000.0, "operating_cash_flow": -71260000.0, "operating_income": -71423000.0, "revenue": 1517000.0, "stockholders_equity": 252188000.0, "total_assets": 300613000.0, "total_liabilities": 48425000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.19201944581026853, "revenue_growth_yoy": 0.0, "roa_avg2y": -0.40181469662600444, "roa_period_end": -0.2433627288241028, "roe_avg2y": -0.5155820542094803, "roe_period_end": -0.2900931051437816 } }, { "accn": "0001564590-22-008112", "filed": "2023-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 24609000.0, "eps_diluted": -1.84, "net_income": -56047000.0, "operating_cash_flow": -50612000.0, "operating_income": -57539000.0, "revenue": 1517000.0, "stockholders_equity": 31600000.0, "total_assets": 63525000.0, "total_liabilities": 31925000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0102848101265822, "revenue_growth_yoy": 0.0, "roa_avg2y": -0.7601500037297492, "roa_period_end": -0.8822825659189294, "roe_avg2y": -1.3242524838446725, "roe_period_end": -1.773639240506329 } }, { "accn": "0001564590-22-008112", "filed": "2022-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 187000.0, "cash": 33769000.0, "free_cash_flow": -68718000.0, "net_income": -73961000.0, "operating_cash_flow": -68531000.0, "operating_income": -75876000.0, "revenue": 1517000.0, "stockholders_equity": 53047000.0, "total_assets": 83938000.0, "total_liabilities": 30891000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5823326484061304, "revenue_growth_yoy": -0.2803605313092979, "roa_avg2y": -0.668954975488866, "roa_period_end": -0.881138459339036, "roe_avg2y": -0.9399870365898606, "roe_period_end": -1.3942541519784342 } }, { "accn": "0001564590-21-012607", "filed": "2021-03-12", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 84000.0, "cash": 35168000.0, "free_cash_flow": -47455000.0, "net_income": -60802000.0, "operating_cash_flow": -47371000.0, "operating_income": -61954000.0, "revenue": 2108000.0, "stockholders_equity": 104319000.0, "total_assets": 137186000.0, "total_liabilities": 32867000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.31506245266921656, "revenue_growth_yoy": 0.7278688524590164, "roa_avg2y": -0.49392564551440094, "roa_period_end": -0.4432084906623125, "roe_avg2y": -0.6452578293306731, "roe_period_end": -0.5828468447742022 } }, { "accn": "0001564590-20-009016", "filed": "2020-03-05", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 261000.0, "cash": 23844000.0, "free_cash_flow": -35418000.0, "net_income": -44472000.0, "operating_cash_flow": -35157000.0, "operating_income": -43766000.0, "revenue": 1220000.0, "stockholders_equity": 84139000.0, "total_assets": 109013000.0, "total_liabilities": 24874000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2956298506043571, "roa_period_end": -0.40795134525240107, "roe_period_end": -0.5285539405032149 } }, { "accn": "0001564590-18-004911", "filed": "2018-03-08", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "capex": "USD" }, "fundamentals": { "capex": 49000.0 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-076536", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001395937.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001395937.json" }, "ticker": "SNDX" }